Why Copilots Failed in R&D and What Comes Next
Organizations that benefit most from AI in R&D will be those that align technology with scientific reality
False
Advertisement
Related Content
Biopharma
Biopharma
Regulation & Standards
China’s Biopharma Homecoming
September 1, 2026
7 min read
Chinese biopharma leaders are returning from the West to build a more confident – and innovative – global industry, says Cyagen’s Lance Han
Development & Clinical
Small Molecules
Interviews
Musings from The Power List: Christine Allen
August 28, 2026
2 min read
Christine Allen believes AI will connect every stage of drug development, but only if it remains guided by human expertise
Biopharma
Industry News
Development & Clinical
Phase III Success Marks Milestone for Personalized Cancer Vaccines
August 26, 2026
7 min read
Merck and Moderna report positive phase III results for intismeran in melanoma, as The Medicine Maker revisits how cancer vaccines work and the challenges still facing the field
Cell & Gene
Development & Clinical
Business & Trends
The Biggest Bottlenecks Holding Back Cell and Gene Therapy
August 24, 2026
9 min read
Members of the 2026 Power List argue that manufacturing, infrastructure, reimbursement, and investment now pose the greatest challenges